Dr. Richard Zelkowitz named Regional Medical Director of the Breast Program for the Fairfield Region

Print icon

Richard Zelkowitz, MD, has been hired as Regional Medical Director of the Breast Program for the Fairfield Region. He brings a wealth of experience and expertise in hematology, oncology and breast health to St. Vincent’s Medical Center and the Hartford HealthCare Cancer Institute.

Dr. Zelkowitz is a familiar presence in Fairfield County, coming to us from Norwalk Hospital, where he joined the medical staff in 1989. While there, he served as chief of hematology/oncology and co-director of the cancer center, as well as a consultant with the Memorial Sloan Kettering Cancer Center Department of Medicine.

A staunch patient advocate keenly focused on both their medical and emotional needs, Dr. Zelkowitz initiated the state’s first breast navigator program to help guide patients and families through their cancer journeys. He initiated and developed a lecture series that attracted nationally-recognized speakers, developed a multidisciplinary breast cancer tumor board and launched the state’s first Cold Cap program to prevent alopecia in breast cancer patients receiving chemotherapy.

Dr. Zelkowitz is a member of the American Society of Clinical Oncology, the CancerCare Connecticut Chapter’s Medical Advisory Board, the American Society of Breast Disease and the New York Metropolitan Breast Cancer Group.

He is board-certified in hematology and oncology. Dr. Zelkowitz completed a fellowship in hematology/oncology through the Brown University School of Medicine and a second fellowship in bone marrow transplant through the Fred Hutchinson Cancer Center in Seattle. He earned his medical degree from New York Medical College.

Dr. Zelkowitz will see patients beginning this Spring at the Elizabeth M. Pfriem SWIM Center for Cancer Care on the St. Vincent’s Medical Center campus. To make a referral, please call 203.874.3830.


What's New

Pancreatic Cancer

Free Pancreatic Care Webinar June 11

The fourth leading cause of cancer death in both men and women, pancreatic cancer, is an aggressive form of the disease that often exhibits few symptoms until it is advanced. Approximately 57,000 Americans will be diagnosed with it this year, according to the American Cancer Society. About 47,000 will die...

Jeffrey A. Flaks

A Message From Hartford HealthCare CEO Jeffrey Flaks

With the concerns about coronavirus and COVID-19, I want to assure you that Hartford HealthCare is doing everything possible to protect the safety and well-being of the people and the communities we serve, and our team of healthcare providers. Our goal is to be ready and prepared for whatever is...

Quite Smoking

Trying to Quit Smoking? Here’s Some Help

Editor’s note: Initial studies have shown that if you smoke and get COVID-19, you’re 14 times more likely than nonsmokers to require intensive treatment. If you’ve considered stopping smoking, now is a good time. By Ellen Anderson Dornelas, PhD Director, Cancer Care Delivery and Disparities Research Hartford Healthcare Cancer Institute...

Pancreatic Cancer Recovery

How to Manage Pancreatic Cancer Treatment’s Side Effects

A pancreatic cancer survivor is any person who is actively facing pancreatic cancer or has faced it at some point. It could be someone who has completed treatment or a patient actively receiving chemotherapy for a limited or long-term management of their disease. Patients treated with chemotherapy experience a variety...

Breast Cancer Awareness

The New Normal for Breast Cancer Survivors

The word “patient” stems from the Latin word patiens, meaning sufferer. Until recently, a diagnosis of cancer conveyed a sense of victimhood and loss of control, hence labels such as “cancer patient” or “cancer victim.” Despite good intentions, these terms left those with a cancer diagnosis feeling isolated and somehow...